Citigroup Inc. (C) Stock Forecast
Data as of May 2, 2026Financial Services · Current price $127.65 (-0.26%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 15, 2026 | Gerard Cassidy | RBC Capital | $139.00 | +8.9% |
| Apr 15, 2026 | John McDonald | Truist Financial | $139.00 | +8.9% |
| Apr 15, 2026 | Manan Gosalia | Morgan Stanley | $144.00 | +12.8% |
| Apr 15, 2026 | Richard Ramsden | Goldman Sachs | $151.00 | +18.3% |
| Apr 15, 2026 | Jason Goldberg | Barclays | $154.00 | +20.6% |
| Feb 17, 2026 | Manan Gosalia | Morgan Stanley | $152.00 | +19.1% |
| Jan 15, 2026 | Erika Najarian | UBS | $132.00 | +3.4% |
| Jan 15, 2026 | Betsy Graseck | Morgan Stanley | $135.00 | +5.8% |
| Jan 15, 2026 | Chris Kotowski | Oppenheimer | $144.00 | +12.8% |
| Jan 5, 2026 | Mike Mayo | Wells Fargo | $150.00 | +17.5% |
| Jan 5, 2026 | Jason Goldberg | Barclays | $146.00 | +14.4% |
| Dec 18, 2025 | John McDonald | Truist Financial | $123.00 | -3.6% |
| Dec 17, 2025 | Steven Chubak | Wolfe Research | $121.00 | -5.2% |
| Nov 24, 2025 | Erika Najarian | UBS | $108.00 | -15.4% |
| Oct 15, 2025 | Betsy Graseck | Morgan Stanley | $134.00 | +5.0% |
| Oct 14, 2025 | Richard Ramsden | Goldman Sachs | $118.00 | -7.6% |
| Sep 16, 2025 | Mike Mayo | Wells Fargo | $125.00 | -2.1% |
| Sep 3, 2025 | John McDonald | Truist Financial | $105.00 | -17.7% |
| Jul 16, 2025 | Chris Kotowski | Oppenheimer | $123.00 | -3.6% |
| Jul 7, 2025 | Glenn Schorr | Evercore ISI | $77.00 | -39.7% |
Top Analysts Covering C
C vs Sector & Market
| Metric | C | Financial Services Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.51 | 2.41 |
| Analyst Count | 28 | 8 | 18 |
| Target Upside | +10.0% | +64.9% | +14.9% |
| P/E Ratio | 15.82 | -5.01 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $91.26B | $93.05B | $94.55B | 14 |
| 2027-03-31 | $23.95B | $24.60B | $25.29B | 5 |
| 2027-06-30 | $23.39B | $24.02B | $24.69B | 5 |
| 2027-09-30 | $23.55B | $24.18B | $24.86B | 5 |
| 2027-12-31 | $23.02B | $23.64B | $24.30B | 5 |
| 2028-03-31 | $25.38B | $26.07B | $26.80B | 4 |
| 2028-06-30 | $25.36B | $26.05B | $26.78B | 4 |
| 2028-09-30 | $25.39B | $26.08B | $26.81B | 4 |
| 2028-12-31 | $24.85B | $25.52B | $26.24B | 4 |
| 2029-12-31 | $104.29B | $106.63B | $109.18B | 3 |
| 2030-12-31 | $109.01B | $111.45B | $114.12B | 6 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $9.64 | $10.80 | $11.32 | 14 |
| 2027-03-31 | $3.12 | $3.23 | $3.35 | 3 |
| 2027-06-30 | $2.99 | $3.10 | $3.21 | 3 |
| 2027-09-30 | $3.13 | $3.24 | $3.36 | 4 |
| 2027-12-31 | $2.79 | $2.89 | $3.00 | 3 |
| 2028-03-31 | $3.46 | $3.58 | $3.71 | 4 |
| 2028-06-30 | $3.40 | $3.52 | $3.65 | 4 |
| 2028-09-30 | $3.39 | $3.51 | $3.64 | 6 |
| 2028-12-31 | $3.11 | $3.22 | $3.34 | 4 |
| 2029-12-31 | $15.40 | $15.85 | $16.34 | 2 |
| 2030-12-31 | $17.58 | $18.10 | $18.66 | 5 |
Frequently Asked Questions
What is the analyst consensus for C?
The consensus among 28 analysts covering Citigroup Inc. (C) is Buy with an average price target of $132.09.
What is the highest price target for C?
The highest price target for C is $154.00, set by Jason Goldberg at Barclays on 2026-04-15.
What is the lowest price target for C?
The lowest price target for C is $41.00, set by Betsy Graseck at Morgan Stanley on 2023-01-12.
How many analysts cover C?
28 analysts have issued ratings for Citigroup Inc. in the past 12 months.
Is C a buy or sell right now?
Based on 28 analyst ratings, C has a consensus rating of Buy (2.00/5) with a +10.0% upside to the consensus target of $132.09.
What are the earnings estimates for C?
Analysts estimate C will report EPS of $10.80 for the period ending 2026-12-31, with revenue estimated at $93.05B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.